The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fatty Acid Synthase (FASN) Inhibitors Market Research Report 2025
Synopsis
Fatty Acid Synthase (FASN) Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide. FASN is a key enzyme involved in the production of saturated fatty acids in the liver and other organs and is the only enzyme in the human body capable of converting metabolized sugars into palmitate. Palmitate is a saturated fatty acid that serves as a building block for longer chain, polyunsaturated fatty acids and can directly interact with other proteins to sustain normal cell signaling and metabolic function. The overproduction of palmitate is a critical driver of cellular metabolic dysfunction that can drive development or progression of several different diseases. In patients with NASH, increased FASN-mediated palmitate synthesis in the liver is the source of three key drivers of the disease: excess accumulation of liver fat, inflammation and fibrosis. If left untreated, these can lead to cirrhosis of the liver, liver cancer and/or liver transplantation.
The global Fatty Acid Synthase (FASN) Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fatty Acid Synthase (FASN) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fatty Acid Synthase (FASN) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Fatty Acid Synthase (FASN) Inhibitors in Medical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Fatty Acid Synthase (FASN) Inhibitors include Merck, Abcam, Tocris Bioscience, MedChemExpress, Sagimet Biosciences, R＆D Systems and Santa Cruz Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fatty Acid Synthase (FASN) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fatty Acid Synthase (FASN) Inhibitors.
Report Scope
The Fatty Acid Synthase (FASN) Inhibitors market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fatty Acid Synthase (FASN) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fatty Acid Synthase (FASN) Inhibitors companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Abcam
Tocris Bioscience
MedChemExpress
Sagimet Biosciences
R＆D Systems
Santa Cruz Biotechnology
Segment by Type
Powder
Solid
Segment by Application
Medical
Research Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fatty Acid Synthase (FASN) Inhibitors companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Fatty Acid Synthase (FASN) Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide. FASN is a key enzyme involved in the production of saturated fatty acids in the liver and other organs and is the only enzyme in the human body capable of converting metabolized sugars into palmitate. Palmitate is a saturated fatty acid that serves as a building block for longer chain, polyunsaturated fatty acids and can directly interact with other proteins to sustain normal cell signaling and metabolic function. The overproduction of palmitate is a critical driver of cellular metabolic dysfunction that can drive development or progression of several different diseases. In patients with NASH, increased FASN-mediated palmitate synthesis in the liver is the source of three key drivers of the disease: excess accumulation of liver fat, inflammation and fibrosis. If left untreated, these can lead to cirrhosis of the liver, liver cancer and/or liver transplantation.
The global Fatty Acid Synthase (FASN) Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fatty Acid Synthase (FASN) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fatty Acid Synthase (FASN) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Fatty Acid Synthase (FASN) Inhibitors in Medical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Fatty Acid Synthase (FASN) Inhibitors include Merck, Abcam, Tocris Bioscience, MedChemExpress, Sagimet Biosciences, R＆D Systems and Santa Cruz Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fatty Acid Synthase (FASN) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fatty Acid Synthase (FASN) Inhibitors.
Report Scope
The Fatty Acid Synthase (FASN) Inhibitors market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fatty Acid Synthase (FASN) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fatty Acid Synthase (FASN) Inhibitors companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Abcam
Tocris Bioscience
MedChemExpress
Sagimet Biosciences
R＆D Systems
Santa Cruz Biotechnology
Segment by Type
Powder
Solid
Segment by Application
Medical
Research Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fatty Acid Synthase (FASN) Inhibitors companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Powder
1.2.3 Solid
1.3 Market by Application
1.3.1 Global Fatty Acid Synthase (FASN) Inhibitors Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical
1.3.3 Research Laboratories
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fatty Acid Synthase (FASN) Inhibitors Market Perspective (2019-2030)
2.2 Fatty Acid Synthase (FASN) Inhibitors Growth Trends by Region
2.2.1 Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fatty Acid Synthase (FASN) Inhibitors Historic Market Size by Region (2019-2024)
2.2.3 Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Region (2025-2030)
2.3 Fatty Acid Synthase (FASN) Inhibitors Market Dynamics
2.3.1 Fatty Acid Synthase (FASN) Inhibitors Industry Trends
2.3.2 Fatty Acid Synthase (FASN) Inhibitors Market Drivers
2.3.3 Fatty Acid Synthase (FASN) Inhibitors Market Challenges
2.3.4 Fatty Acid Synthase (FASN) Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fatty Acid Synthase (FASN) Inhibitors Players by Revenue
3.1.1 Global Top Fatty Acid Synthase (FASN) Inhibitors Players by Revenue (2019-2024)
3.1.2 Global Fatty Acid Synthase (FASN) Inhibitors Revenue Market Share by Players (2019-2024)
3.2 Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fatty Acid Synthase (FASN) Inhibitors Revenue
3.4 Global Fatty Acid Synthase (FASN) Inhibitors Market Concentration Ratio
3.4.1 Global Fatty Acid Synthase (FASN) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fatty Acid Synthase (FASN) Inhibitors Revenue in 2023
3.5 Fatty Acid Synthase (FASN) Inhibitors Key Players Head office and Area Served
3.6 Key Players Fatty Acid Synthase (FASN) Inhibitors Product Solution and Service
3.7 Date of Enter into Fatty Acid Synthase (FASN) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fatty Acid Synthase (FASN) Inhibitors Breakdown Data by Type
4.1 Global Fatty Acid Synthase (FASN) Inhibitors Historic Market Size by Type (2019-2024)
4.2 Global Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Type (2025-2030)
5 Fatty Acid Synthase (FASN) Inhibitors Breakdown Data by Application
5.1 Global Fatty Acid Synthase (FASN) Inhibitors Historic Market Size by Application (2019-2024)
5.2 Global Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fatty Acid Synthase (FASN) Inhibitors Market Size (2019-2030)
6.2 North America Fatty Acid Synthase (FASN) Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2019-2024)
6.4 North America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fatty Acid Synthase (FASN) Inhibitors Market Size (2019-2030)
7.2 Europe Fatty Acid Synthase (FASN) Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2019-2024)
7.4 Europe Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size (2019-2030)
8.2 Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (2019-2024)
8.4 Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size (2019-2030)
9.2 Latin America Fatty Acid Synthase (FASN) Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2019-2024)
9.4 Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size (2019-2030)
10.2 Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2019-2024)
10.4 Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Fatty Acid Synthase (FASN) Inhibitors Introduction
11.1.4 Merck Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Abcam
11.2.1 Abcam Company Detail
11.2.2 Abcam Business Overview
11.2.3 Abcam Fatty Acid Synthase (FASN) Inhibitors Introduction
11.2.4 Abcam Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
11.2.5 Abcam Recent Development
11.3 Tocris Bioscience
11.3.1 Tocris Bioscience Company Detail
11.3.2 Tocris Bioscience Business Overview
11.3.3 Tocris Bioscience Fatty Acid Synthase (FASN) Inhibitors Introduction
11.3.4 Tocris Bioscience Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
11.3.5 Tocris Bioscience Recent Development
11.4 MedChemExpress
11.4.1 MedChemExpress Company Detail
11.4.2 MedChemExpress Business Overview
11.4.3 MedChemExpress Fatty Acid Synthase (FASN) Inhibitors Introduction
11.4.4 MedChemExpress Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
11.4.5 MedChemExpress Recent Development
11.5 Sagimet Biosciences
11.5.1 Sagimet Biosciences Company Detail
11.5.2 Sagimet Biosciences Business Overview
11.5.3 Sagimet Biosciences Fatty Acid Synthase (FASN) Inhibitors Introduction
11.5.4 Sagimet Biosciences Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
11.5.5 Sagimet Biosciences Recent Development
11.6 R＆D Systems
11.6.1 R＆D Systems Company Detail
11.6.2 R＆D Systems Business Overview
11.6.3 R＆D Systems Fatty Acid Synthase (FASN) Inhibitors Introduction
11.6.4 R＆D Systems Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
11.6.5 R＆D Systems Recent Development
11.7 Santa Cruz Biotechnology
11.7.1 Santa Cruz Biotechnology Company Detail
11.7.2 Santa Cruz Biotechnology Business Overview
11.7.3 Santa Cruz Biotechnology Fatty Acid Synthase (FASN) Inhibitors Introduction
11.7.4 Santa Cruz Biotechnology Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
11.7.5 Santa Cruz Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Powder
Table 3. Key Players of Solid
Table 4. Global Fatty Acid Synthase (FASN) Inhibitors Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Region (2019-2024)
Table 8. Global Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Region (2025-2030)
Table 10. Fatty Acid Synthase (FASN) Inhibitors Market Trends
Table 11. Fatty Acid Synthase (FASN) Inhibitors Market Drivers
Table 12. Fatty Acid Synthase (FASN) Inhibitors Market Challenges
Table 13. Fatty Acid Synthase (FASN) Inhibitors Market Restraints
Table 14. Global Fatty Acid Synthase (FASN) Inhibitors Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Players (2019-2024)
Table 16. Global Top Fatty Acid Synthase (FASN) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Acid Synthase (FASN) Inhibitors as of 2023)
Table 17. Ranking of Global Top Fatty Acid Synthase (FASN) Inhibitors Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Fatty Acid Synthase (FASN) Inhibitors Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fatty Acid Synthase (FASN) Inhibitors Product Solution and Service
Table 21. Date of Enter into Fatty Acid Synthase (FASN) Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Fatty Acid Synthase (FASN) Inhibitors Revenue Market Share by Type (2019-2024)
Table 25. Global Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Fatty Acid Synthase (FASN) Inhibitors Revenue Market Share by Type (2025-2030)
Table 27. Global Fatty Acid Synthase (FASN) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Fatty Acid Synthase (FASN) Inhibitors Revenue Market Share by Application (2019-2024)
Table 29. Global Fatty Acid Synthase (FASN) Inhibitors Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Fatty Acid Synthase (FASN) Inhibitors Revenue Market Share by Application (2025-2030)
Table 31. North America Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Fatty Acid Synthase (FASN) Inhibitors Product
Table 49. Merck Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Abcam Company Detail
Table 52. Abcam Business Overview
Table 53. Abcam Fatty Acid Synthase (FASN) Inhibitors Product
Table 54. Abcam Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024) & (US$ Million)
Table 55. Abcam Recent Development
Table 56. Tocris Bioscience Company Detail
Table 57. Tocris Bioscience Business Overview
Table 58. Tocris Bioscience Fatty Acid Synthase (FASN) Inhibitors Product
Table 59. Tocris Bioscience Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024) & (US$ Million)
Table 60. Tocris Bioscience Recent Development
Table 61. MedChemExpress Company Detail
Table 62. MedChemExpress Business Overview
Table 63. MedChemExpress Fatty Acid Synthase (FASN) Inhibitors Product
Table 64. MedChemExpress Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024) & (US$ Million)
Table 65. MedChemExpress Recent Development
Table 66. Sagimet Biosciences Company Detail
Table 67. Sagimet Biosciences Business Overview
Table 68. Sagimet Biosciences Fatty Acid Synthase (FASN) Inhibitors Product
Table 69. Sagimet Biosciences Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024) & (US$ Million)
Table 70. Sagimet Biosciences Recent Development
Table 71. R＆D Systems Company Detail
Table 72. R＆D Systems Business Overview
Table 73. R＆D Systems Fatty Acid Synthase (FASN) Inhibitors Product
Table 74. R＆D Systems Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024) & (US$ Million)
Table 75. R＆D Systems Recent Development
Table 76. Santa Cruz Biotechnology Company Detail
Table 77. Santa Cruz Biotechnology Business Overview
Table 78. Santa Cruz Biotechnology Fatty Acid Synthase (FASN) Inhibitors Product
Table 79. Santa Cruz Biotechnology Revenue in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024) & (US$ Million)
Table 80. Santa Cruz Biotechnology Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fatty Acid Synthase (FASN) Inhibitors Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Type: 2023 VS 2030
Figure 3. Powder Features
Figure 4. Solid Features
Figure 5. Global Fatty Acid Synthase (FASN) Inhibitors Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Application: 2023 VS 2030
Figure 7. Medical Case Studies
Figure 8. Research Laboratories Case Studies
Figure 9. Other Case Studies
Figure 10. Fatty Acid Synthase (FASN) Inhibitors Report Years Considered
Figure 11. Global Fatty Acid Synthase (FASN) Inhibitors Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Fatty Acid Synthase (FASN) Inhibitors Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Region: 2023 VS 2030
Figure 14. Global Fatty Acid Synthase (FASN) Inhibitors Market Share by Players in 2023
Figure 15. Global Top Fatty Acid Synthase (FASN) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Acid Synthase (FASN) Inhibitors as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Fatty Acid Synthase (FASN) Inhibitors Revenue in 2023
Figure 17. North America Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Fatty Acid Synthase (FASN) Inhibitors Market Share by Country (2019-2030)
Figure 19. United States Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Fatty Acid Synthase (FASN) Inhibitors Market Share by Country (2019-2030)
Figure 23. Germany Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Fatty Acid Synthase (FASN) Inhibitors Market Share by Region (2019-2030)
Figure 31. China Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Fatty Acid Synthase (FASN) Inhibitors Market Share by Country (2019-2030)
Figure 39. Mexico Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Fatty Acid Synthase (FASN) Inhibitors Market Share by Country (2019-2030)
Figure 43. Turkey Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Fatty Acid Synthase (FASN) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
Figure 46. Abcam Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
Figure 47. Tocris Bioscience Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
Figure 48. MedChemExpress Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
Figure 49. Sagimet Biosciences Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
Figure 50. R＆D Systems Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
Figure 51. Santa Cruz Biotechnology Revenue Growth Rate in Fatty Acid Synthase (FASN) Inhibitors Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
